Literature DB >> 15456995

Prior lung disease and risk of lung cancer in a large prospective study.

Alyson J Littman1, Mark D Thornquist, Emily White, Lisa A Jackson, Gary E Goodman, Thomas L Vaughan.   

Abstract

OBJECTIVES: While 75-90% of people who develop lung cancer are smokers, only a small proportion of smokers develop lung cancer. Identifying factors that increase a smoker's risk of developing lung cancer may help scientists to better understand the etiology of lung cancer and more effectively target high-risk groups for screening.
METHODS: Information on physician-diagnosed non-malignant lung diseases [asbestosis, asthma, chronic bronchitis or emphysema (CB/E), pneumonia, and tuberculosis] was obtained at baseline from 17,698 men and women involved in CARET, a randomized lung cancer prevention trial of beta-carotene and vitamin A among heavy smokers and asbestos-exposed workers. Hazard ratios for lung cancer were estimated through Cox regression models, after controlling for potential confounding factors, included smoking. Analyses were restricted to former and current smokers.
RESULTS: During a median follow up of 9.1 years, 1028 cases of lung cancer occurred. Those who developed lung cancer were more likely to report a history of CB/E than controls (adjusted HR = 1.29, 95% CI: 1.09-1.53). In subgroup analyses, the association between a history of CB/E and lung cancer was stronger for those who were younger at diagnosis/reference, men in the heavy smoker cohort, former smokers, and those with squamous cell carcinomas. There was little association between a history of other lung diseases and lung cancer.
CONCLUSIONS: Smokers with a history of CB/E may be at higher risk of developing lung cancer, independent of their smoking history.

Entities:  

Mesh:

Year:  2004        PMID: 15456995     DOI: 10.1023/B:CACO.0000043432.71626.45

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  37 in total

1.  Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.

Authors:  Cesar E Ochoa; Seyedeh Golsar Mirabolfathinejad; Venado Ana Ruiz; Scott E Evans; Mihai Gagea; Christopher M Evans; Burton F Dickey; Seyed Javad Moghaddam
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-22

2.  Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility.

Authors:  Keith D Eaton; Perrin E Romine; Gary E Goodman; Mark D Thornquist; Matt J Barnett; Effie W Petersdorf
Journal:  J Thorac Oncol       Date:  2018-03-23       Impact factor: 15.609

3.  The potential for malignancy from atopic disorders and allergic inflammation: A systematic review and meta-analysis.

Authors:  Amanda B Muir; Kelly A Whelan; Michael K Dougherty; Bailey Aaron; Brianna Navarre; Seema S Aceves; Evan S Dellon; Elizabeth T Jensen
Journal:  Clin Exp Allergy       Date:  2019-12-20       Impact factor: 5.018

4.  A new role for microRNAs, as ligands of Toll-like receptors.

Authors:  Muller Fabbri; Alessio Paone; Federica Calore; Roberta Galli; Carlo M Croce
Journal:  RNA Biol       Date:  2013-01-07       Impact factor: 4.652

5.  The relationship between chronic obstructive pulmonary disease and lung cancer in African American patients.

Authors:  Nader Mina; Ayman O Soubani; Michele L Cote; Tariq Suwan; Angie S Wenzlaff; Sunil Jhajhria; Husam Samarah; Ann G Schwartz
Journal:  Clin Lung Cancer       Date:  2011-11-29       Impact factor: 4.785

6.  Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance.

Authors:  Julien Cherfils-Vicini; Sophia Platonova; Mélanie Gillard; Ludivine Laurans; Pierre Validire; Rafaele Caliandro; Pierre Magdeleinat; Fathia Mami-Chouaib; Marie-Caroline Dieu-Nosjean; Wolf-Herman Fridman; Diane Damotte; Catherine Sautès-Fridman; Isabelle Cremer
Journal:  J Clin Invest       Date:  2010-03-08       Impact factor: 14.808

7.  Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study.

Authors:  Anish Thomas; Idrees Mian; Camille Tlemsani; Lorinc Pongor; Nobuyuki Takahashi; Kathleen Maignan; Jeremy Snider; Gerald Li; Garrett Frampton; Siraj Ali; Sehyun Kim; Samantha Nichols; Vinodh Rajapakse; Udayan Guha; Elad Sharon; Junya Fujimoto; Cesar A Moran; Ignacio I Wistuba; Jun S Wei; Javed Khan; Eva Szabo; Aracelis Z Torres; Kenneth R Carson
Journal:  Chest       Date:  2020-05-26       Impact factor: 9.410

8.  Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans.

Authors:  Michelle K McHugh; Matthew B Schabath; Chung-Han Ho; Mei Liu; Anthony M D'Amelio; Anthony J Greisinger; George L Delclos; Margaret R Spitz; Carol J Etzel
Journal:  J Immigr Minor Health       Date:  2013-10

Review 9.  Lung Malignancies in HIV Infection.

Authors:  Keith Sigel; Robert Pitts; Kristina Crothers
Journal:  Semin Respir Crit Care Med       Date:  2016-03-14       Impact factor: 3.119

10.  Dietary magnesium and DNA repair capacity as risk factors for lung cancer.

Authors:  Somdat Mahabir; Qingyi Wei; Stephanie L Barrera; Yong Quan Dong; Carol J Etzel; Margaret R Spitz; Michele R Forman
Journal:  Carcinogenesis       Date:  2008-04-30       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.